FIELD: medicine.
SUBSTANCE: according to the invention there is provided a spray-type nasal medicine containing active and additive agents, natural minerals and microelements, wherein natural sea-salt is used as active agent, water for injection is used as additive agent where osmolality of isotonic sterile solution makes 220 to 350 mmole/kg of water and pH from 6.0 to 9.5 and contains ions of natrium, magnesium, calcium, kalium and hydrocarbonates. The medicine is intended for active irrigation, rhinenchysis and cleansing nasal cavity, free nasal breathing management, prevention and treatment for infection of upper air passages.
EFFECT: components forming part of active agent complement and potentiate each other.
2 cl, 2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR NASAL APPLICATION, BASED THERAPEUTIC AGENT AND METHOD FOR USING SAME | 2014 |
|
RU2540496C1 |
| COMPOSITION FOR NASAL PREPARATION | 2015 |
|
RU2605617C1 |
| PHARMACEUTIC COMPOSITION IN FORM OF FLUCONASOLE SOLUTION, POSSESSING ANTIFUNGAL ACTIVITY | 2010 |
|
RU2419417C1 |
| NONSTEROID ANTIINFLAMMATORY MEDICINAL AGENT | 2007 |
|
RU2345775C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF UPPER RESPIRATORY TRACT DISEASES AND MEDICINAL PRODUCT BASED THEREON | 2019 |
|
RU2748548C1 |
| MEANS FOR NASAL CAVITY, NASOPHARYNX AND ORAL CAVITY RINSING | 2016 |
|
RU2637438C1 |
| MEANS FOR NASAL APPLICATION | 2016 |
|
RU2629330C1 |
| TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADIN | 2014 |
|
RU2799761C2 |
| THERAPEUTIC AGENT CONTAINING COMBINATION OF ACTIVE SUBSTANCES CONTAINING PANTOTHENIC ACID OR ITS DERIVATIVES FOR TREATING ALLERGIC SYMPTOMS | 2008 |
|
RU2472499C2 |
| TREATMENT OF ALLERGIC RHINITIS IN PEDIATRIC CATEGORY USING A COMBINATION OF MOMETASONE AND OLOPATADINE | 2019 |
|
RU2798030C2 |
